Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)
Clinical trial NCT04265027 · COMPLETED
Trial details
- NCT number
- NCT04265027
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2018-07-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.